Bottom Line: An analysis of prescription drug coverage policies for the treatment of low back pain suggests insurers could help to reduce opioid overuse by expanding access to opioid alternatives through coverage and reimbursement policies.
Why The Research Is Interesting: Little is known about medication coverage policies among U.S. insurers for the treatment of chronic noncancer pain.
Who, What and When: Health plan documents from 15 Medicaid, 15 Medicare Advantage and 20 commercial health plans in 2017 from 16 states representing more than half of the U.S. population; 20 interviews with more than 43 senior medical and pharmacy health plan executives from representative plans
What (Study Measures and Outcomes): Formulary coverage, utilization management and patient out-of-pocket costs
How (Study Design): This was an observational study. Researchers were not intervening for purposes of the study and cannot control all the natural differences that could explain the study findings.
Authors: G. Caleb Alexander, M.D., M.S., Johns Hopkins Bloomberg School of Public Health, Baltimore, and coauthors
Study Limitations: Publicly available documents were not consistently available for all payers; some health systems and payers, such as the Veterans Health Administration and workers' compensation plans, weren't included.
Study Conclusions: The findings suggest opportunities for insurers to redesign coverage policies to improve pain management and reduce opioid-related injuries and deaths.
Related material: The commentary, "Opioid Prescribing for Low Back Pain," by Jennifer F. Waljee, M.D., M.P.H., and Chad M. Brummett, M.D., of the University of Michigan, Ann Arbor is also available on the For The Media website.
To Learn More: The full study is available on the For The Media website.
(doi:10.1001/jamanetworkopen.2018.0235)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
Want to embed a link to this study in your story? Link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2018.0235
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Media Contact
Barbara Benham
[email protected]
@ JAMANetworkOpen
http://dx.doi.org/10.1001/jamanetworkopen.2018.0235
